OTTAWA, ON--(Marketwired - December 01, 2014) - The Hydropothecary today announced receipt of its production license for medical marijuana. The license is held by the company's wholly-owned subsidiary, 167151 Canada Inc., which is listed as the licensee on Health Canada's website.

"Receiving a production license from Health Canada is an exciting development and is a recognition of good planning, strong management and hard work. We're excited to be at the forefront of this new industry and setting the benchmark for customer service," says co-founder and chief operating officer, Adam Miron.

The company is strongly committed to research and development, says president and CEO, Sebastien St-Louis.

"We're heavily focused on research and development and have assembled a great team, including a vice-president of quality with 22 years of experience at a major pharmaceutical firm, a medical director and a chemical engineer," he says.

The Hydropothecary recently completed a successful first harvest at its facility in Gatineau, Quebec under the direction of operations manager Louis Gagnon and his team, who have 30 years of award-winning horticultural experience.

The Hydropothecary is a Canadian medical marijuana producer and distributor based in the National Capital Region, with facilities along Rivière des Outaouais in Gatineau, Quebec. The Hydropothecary offers around the clock concierge service and guarantees supply to all its customers. With a strong commitment to R&D, the Hydropothecary currently has four products, Good Morning, Midday, After Dinner and Bedtime. Prices start at $26/g. The Hydropothecary is a registered business name of The Hydropothecary Corporation.

Contact Information:

For more information or to arrange interviews, please contact
Julie Beun